Growth Metrics

Boston Scientific (BSX) Shares Outstanding (Weighted Average) (2016 - 2026)

Boston Scientific's Shares Outstanding (Weighted Average) history spans 18 years, with the latest figure at $1.5 billion for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 0.52% to $1.5 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $1.5 billion, a 0.52% increase, with the full-year FY2025 number at $1.5 billion, up 0.6% from a year prior.
  • Shares Outstanding (Weighted Average) hit $1.5 billion in Q1 2026 for Boston Scientific, roughly flat from $1.5 billion in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for BSX hit a ceiling of $1.5 billion in Q1 2026 and a floor of $1.4 billion in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $1.5 billion across 5 years, with a median of $1.5 billion in 2024.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 2.27% in 2024 and later grew 0.52% in 2026.
  • Tracing BSX's Shares Outstanding (Weighted Average) over 5 years: stood at $1.4 billion in 2022, then rose by 1.57% to $1.5 billion in 2023, then rose by 1.27% to $1.5 billion in 2024, then grew by 0.6% to $1.5 billion in 2025, then rose by 0.3% to $1.5 billion in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for BSX at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.